Congress is back in session with a loaded agenda for the lame duck period. One of the top issues the life sciences industry is tracking is the potential passage of the BIOSECURE Act. Speaker Johnson has signaled the House...more
11/20/2024
/ Biotechnology ,
Congressional Committees ,
Grandfathering Rules ,
Healthcare ,
Lame Duck Session ,
Legislative Agendas ,
Life Sciences ,
Pending Legislation ,
Proposed Legislation ,
Senate Committees ,
U.S. House
Members from both parties in the House and Senate have introduced legislation in both houses (H.R. 7085 / S. 3558) to bar federal agencies from entering into:
Contracts, loans, or grant agreements for biotechnology...more